Prospera Financial Services Inc Co Diagnostics, Inc. Transaction History

Prospera Financial Services Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$3.76 - $6.29 $9,588 - $16,039	-2,550 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$5.03 - $9.61 $12,826 - $24,505	2,550 New	2,550 $16,000
Q4 2020 Feb 12, 2021	SELL	$9.3 - $15.19 $22,785 - $37,215	-2,450 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$8.24 - $30.8 $20,188 - $75,460	2,450 New	2,450 $33,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $27.4M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.